Form 4: Elevance Health EVP & CFO Mark Kaye Sells Shares
SEC Form 4
Elevance Health's EVP & CFO, Mark Kaye, sold 4,588 shares of common stock at $424.82 per share on April 24, 2025.
Summary
- On April 24, 2025, Mark Kaye, the EVP & CFO of Elevance Health, Inc., sold 4,588 shares of the company's common stock.
- The sale was executed at a price of $424.82 per share.
- Following the transaction, Kaye directly owns 18,977 shares of Elevance Health common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The sale itself doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to periodically sell shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 04/24/2025 | Date of the transaction: Mark Kaye sold 4,588 shares of Elevance Health common stock. |
| 04/25/2025 | Date of signature on the Form 4 filing. |
Keywords
Elevance Health, ELV, Mark Kaye, CFO, stock sale, Form 4, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.